"Nephrectomy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Excision of kidney.
| Descriptor ID |
D009392
|
| MeSH Number(s) |
E04.950.774.435
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Nephrectomy".
Below are MeSH descriptors whose meaning is more specific than "Nephrectomy".
This graph shows the total number of publications written about "Nephrectomy" by people in this website by year, and whether "Nephrectomy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 1 | 1 | 2 |
| 2007 | 2 | 0 | 2 |
| 2008 | 0 | 1 | 1 |
| 2009 | 2 | 1 | 3 |
| 2012 | 0 | 2 | 2 |
| 2013 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 3 | 2 | 5 |
| 2017 | 48 | 20 | 68 |
| 2018 | 52 | 17 | 69 |
| 2019 | 22 | 14 | 36 |
| 2020 | 2 | 0 | 2 |
| 2021 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Nephrectomy" by people in Profiles.
-
Impact of the first surge of the COVID-19 pandemic on a tertiary referral centre for kidney cancer. BJU Int. 2021 12; 128(6):752-758.
-
Delayed surgery for localised and metastatic renal cell carcinoma: a systematic review and meta-analysis for the COVID-19 pandemic. World J Urol. 2021 Dec; 39(12):4295-4303.
-
Challenging Cases of Renal Cell Cancers With or Without Tumor Thrombus During the Covid-19 Pandemic. Anticancer Res. 2021 Jan; 41(1):335-340.
-
Delaying surgery for clinical T1b-T2bN0M0 renal cell carcinoma: Oncologic implications in the COVID-19 era and beyond. Urol Oncol. 2021 05; 39(5):247-257.
-
Association of Surgical Delay and Overall Survival in Patients With T2 Renal Masses: Implications for Critical Clinical Decision-making During the COVID-19 Pandemic. Urology. 2021 01; 147:50-56.
-
Consideration in the management of renal cell carcinoma during the COVID-19 Pandemic. Int Braz J Urol. 2020 07; 46(suppl.1):69-78.
-
[Current status for urpper tract transitional cell carcinoma during COVID-19 pandemia.] Arch Esp Urol. 2020 Jun; 73(5):384-389.
-
Reply to Vincenzo Ficarra, Giuseppe Mucciardi, and Gianluca Giannarini's Letter to the Editor re: Riccardo Campi, Daniele Amparore, Umberto Capitanio, et al. Assessing the Burden of Nondeferrable Major Uro-oncologic Surgery to Guide Prioritisation Strategies During the COVID-19 Pandemic: Insights from Three Italian High-volume Referral Centres. Eur Urol2020;78:11-15. Eur Urol. 2020 10; 78(4):e169-e170.
-
Re: Riccardo Campi, Daniele Amparore, Umberto Capitanio, et al. Assessing the burden of nondeferrable major uro-oncologic surgery to guide prioritisation strategies during the COVID-19 pandemic: insights from three Italian high-volume referral centres. Eur Urol 2020;78:11-15. Eur Urol. 2020 07; 78(1):e16-e17.
-
Which patients with clinical localized renal mass would achieve the trifecta after partial nephrectomy? The impact of surgical technique. Minerva Urol Nefrol. 2020 Jun; 72(3):339-349.